abstract |
The present invention relates to interferon compositions for oral mucosal administration for stimulating anti-tumor responses in mammals comprising a therapeutically effective amount of interferon. The therapeutically effective amount of interferon is an amount that does not induce a pathological response upon parenteral administration. |